Genky DrugStores Beheer

Beheer criteriumcontroles 2/4

De CEO Genky DrugStores is Kenichi Fujinaga, benoemd in Dec2017, heeft een ambtstermijn van 6.92 jaar. bezit rechtstreeks 20.92% van de aandelen van het bedrijf, ter waarde ¥ 19.96B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.8 jaar en 4.2 jaar.

Belangrijke informatie

Kenichi Fujinaga

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	6.9yrs
Eigendom CEO	20.9%
Management gemiddelde ambtstermijn	6.8yrs
Gemiddelde ambtstermijn bestuur	4.2yrs

Recente managementupdates

Recent updates

Genky DrugStores Co., Ltd. (TSE:9267) Just Reported And Analysts Have Been Lifting Their Price Targets

Oct 30

What Genky DrugStores Co., Ltd.'s (TSE:9267) 28% Share Price Gain Is Not Telling You

Aug 07

Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600

Apr 27

Return Trends At Genky DrugStores (TSE:9267) Aren't Appealing

Mar 07

CEO

Kenichi Fujinaga (62 yo)

6.9yrs

Tenure

Mr. Kenichi Fujinaga is the Founder of Genky DrugStores Co., Ltd. (formerly known as Genky Stores, Inc.). and has been its President since December 2017 and serves as its CEO. Mr. Fujinaga is the Founder o...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kenichi Fujinaga	President	6.9yrs	geen gegevens	20.92% ¥ 20.0b
Takeshi Tsunemi	Executive Officer and Finance & Investor Relations Manager	no data	geen gegevens	geen gegevens
Yuji Kobayashi	Executive Officer	6.8yrs	geen gegevens	0.050% ¥ 47.9m
Nobuhiro Yoshioka	VP of Product Division & Director	5.3yrs	geen gegevens	0.33% ¥ 311.5m

6.8yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 9267 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kenichi Fujinaga	President	16.2yrs	geen gegevens	20.92% ¥ 20.0b
Yuji Kobayashi	Executive Officer	4.2yrs	geen gegevens	0.050% ¥ 47.9m
Nobuhiro Yoshioka	VP of Product Division & Director	24.2yrs	geen gegevens	0.33% ¥ 311.5m
Hiroyuki Yamagata	Director	19.2yrs	geen gegevens	0.28% ¥ 263.8m
Nana Yoshikawa	Independent Outside Director	1.2yrs	geen gegevens	geen gegevens
Tomoyo Sasaki	Independent Outside Director	1.2yrs	geen gegevens	geen gegevens
Miho Takeda	Independent Outside Director	1.2yrs	geen gegevens	geen gegevens

4.2yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 9267 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).

Genky DrugStores Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Genky DrugStores Co., Ltd., Annual General Meeting, Sep 12, 2024

Genky DrugStores Co., Ltd., Annual General Meeting, Sep 07, 2023

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Genky DrugStores Co., Ltd. to Report Q2, 2025 Results on Jan 27, 2025

Genky DrugStores Co., Ltd. (TSE:9267) Just Reported And Analysts Have Been Lifting Their Price Targets

First quarter 2025 earnings released: EPS: JP¥52.13 (vs JP¥47.54 in 1Q 2024)

Final dividend of JP¥6.50 announced

Price target increased by 11% to JP¥4,300

Genky DrugStores Co., Ltd. to Report Q1, 2025 Results on Oct 28, 2024

What Genky DrugStores Co., Ltd.'s (TSE:9267) 28% Share Price Gain Is Not Telling You

Full year 2024 earnings: EPS exceeds analyst expectations

New minor risk - Share price stability

Investor sentiment improves as stock rises 21%

Genky DrugStores Co., Ltd., Annual General Meeting, Sep 12, 2024

Upcoming dividend of JP¥13.00 per share

Genky DrugStores Co., Ltd. to Report Fiscal Year 2024 Results on Jul 29, 2024

Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600

Third quarter 2024 earnings released: EPS: JP¥90.14 (vs JP¥68.63 in 3Q 2023)

Consensus EPS estimates increase by 13%

Return Trends At Genky DrugStores (TSE:9267) Aren't Appealing

Genky DrugStores Co., Ltd. to Report Q3, 2024 Results on Apr 25, 2024

First half dividend of JP¥12.50 announced

Second quarter 2024 earnings released: EPS: JP¥108 (vs JP¥77.00 in 2Q 2023)

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2024

New minor risk - Share price stability

Upcoming dividend of JP¥12.50 per share at 0.5% yield

Genky DrugStores Co., Ltd. to Report Q2, 2024 Results on Jan 29, 2024

First quarter 2024 earnings released: EPS: JP¥95.08 (vs JP¥72.58 in 1Q 2023)

Genky Drugstores Co., Ltd. Provides Dividend Guidance for Second Quarter and Full Year of Year Ending June 20, 2024

Genky DrugStores Co., Ltd. to Report Q1, 2024 Results on Oct 30, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Genky DrugStores Co., Ltd., Annual General Meeting, Sep 07, 2023

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

Upcoming dividend of JP¥12.50 per share at 0.6% yield

Genky DrugStores Co., Ltd. to Report Fiscal Year 2023 Results on Jul 24, 2023

Third quarter 2023 earnings released: EPS: JP¥68.63 (vs JP¥61.46 in 3Q 2022)

Price target increased by 9.3% to JP¥4,700

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2023

Second quarter 2023 earnings released: EPS: JP¥77.00 (vs JP¥59.30 in 2Q 2022)

Genky DrugStores Co., Ltd. to Report Q2, 2023 Results on Jan 31, 2023

Upcoming dividend of JP¥12.50 per share

Less than half of directors are independent

First quarter 2023 earnings released: EPS: JP¥72.58 (vs JP¥81.18 in 1Q 2022)

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending June 20, 2023 and Full Year Ending June 20, 2023

Genky DrugStores Co., Ltd. to Report Q1, 2023 Results on Oct 24, 2022

Consensus EPS estimates fall by 12%

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending June 20, 2023

Genky DrugStores Co., Ltd. to Report Fiscal Year 2022 Results on Jul 26, 2022

Upcoming dividend of JP¥12.50 per share

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to JP¥5,700

Less than half of directors are independent

Genky DrugStores Co., Ltd. to Report Q3, 2022 Results on Apr 26, 2022

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Genky Drugstores Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Upcoming dividend of JP¥12.50 per share

First quarter 2022 earnings released: EPS JP¥81.18 (vs JP¥84.86 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥318 (vs JP¥182 in FY 2020)

Upcoming dividend of JP¥12.50 per share

Third quarter 2021 earnings released: EPS JP¥64.31 (vs JP¥64.70 in 3Q 2020)

Genky DrugStores Co., Ltd. to Report Q3, 2021 Results on Apr 20, 2021

New 90-day low: JP¥3,720

New 90-day low: JP¥3,795

Second quarter 2021 earnings released: EPS JP¥75.64

Upcoming Dividend of JP¥12.50 Per Share

Genky DrugStores Co., Ltd. to Report Q2, 2021 Results on Jan 20, 2021

Genky DrugStores Co., Ltd. to Report Q1, 2021 Results on Oct 20, 2020

CEO

Tenure

Leiderschapsteam